213 related articles for article (PubMed ID: 6456708)
21. A randomized controlled clinical trial on piperacillin/tazobactam versus ticarcillin/clavulanic acid for the treatment of bacterial infections.
Hou F; Li J; Gao L; Chen Y
Chin Med J (Engl); 1998 Nov; 111(11):1039-43. PubMed ID: 11189212
[TBL] [Abstract][Full Text] [Related]
22. Moxalactam therapy for bacterial infections.
Winston DJ; Busuttil RW; Kurtz TO; Young LS
Arch Intern Med; 1981 Nov; 141(12):1607-12. PubMed ID: 6458253
[TBL] [Abstract][Full Text] [Related]
23. [Piperacillin. A clinical trial in severe infections (author's transl)].
Ruiz-Palacios GM; Zamora J; Huazano F
Rev Invest Clin; 1981; 33(3):253-7. PubMed ID: 6460307
[No Abstract] [Full Text] [Related]
24. [Piperacillin in urinary tract infections in old age].
Policicchio D; D'Ambrosio P; Vasto P; Sorrentino P; Lingetti E; Buonopane G
G Ital Chemioter; 1981; 28(1-2):5-7. PubMed ID: 6215280
[No Abstract] [Full Text] [Related]
25. [Piperacillin/tazobactam--Tazocin. A penicillin-based alternative to 3rd generation cephalosporins and carbapenems].
Schønning K; Tvede M
Ugeskr Laeger; 2002 May; 164(20):2606-10. PubMed ID: 12043402
[TBL] [Abstract][Full Text] [Related]
26. Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms.
Trouillet JL; Vuagnat A; Combes A; Kassis N; Chastre J; Gibert C
Clin Infect Dis; 2002 Apr; 34(8):1047-54. PubMed ID: 11914992
[TBL] [Abstract][Full Text] [Related]
27. [Clinical trial of an association of 2 semisynthetic penicillins: dicloxacillin and hetacillin].
Fici F; Abbate GF; Astarita C; Gattoni A
Minerva Med; 1973 Nov; 64(82):4325-31. PubMed ID: 4587771
[No Abstract] [Full Text] [Related]
28. [Clinical results with mezlocillin (author's transl)].
Tettenborn D; Schacht P; Hullmann R; Bruck H
Arzneimittelforschung; 1979; 29(12a):2009-14. PubMed ID: 543914
[No Abstract] [Full Text] [Related]
29. Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.
Nagao T; Komatsuda M; Yamauchi K; Nozaki H; Arimori S
Tokai J Exp Clin Med; 1981 Oct; 6(4):415-20. PubMed ID: 6459664
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers].
Konopka CA
Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600
[TBL] [Abstract][Full Text] [Related]
31. Antibiotic resistance in outpatient urinary isolates: final results from the North American Urinary Tract Infection Collaborative Alliance (NAUTICA).
Zhanel GG; Hisanaga TL; Laing NM; DeCorby MR; Nichol KA; Palatnik LP; Johnson J; Noreddin A; Harding GK; Nicolle LE; Hoban DJ;
Int J Antimicrob Agents; 2005 Nov; 26(5):380-8. PubMed ID: 16243229
[TBL] [Abstract][Full Text] [Related]
32. Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003).
Shigemura K; Arakawa S; Sakai Y; Kinoshita S; Tanaka K; Fujisawa M
Int J Urol; 2006 May; 13(5):538-42. PubMed ID: 16771722
[TBL] [Abstract][Full Text] [Related]
33. Results of the North American trial of piperacillin/tazobactam compared with clindamycin and gentamicin in the treatment of severe intra-abdominal infections. Investigators of the Piperacillin/Tazobactam Intra-abdominal Infection Study Group.
Eur J Surg Suppl; 1994; (573):61-6. PubMed ID: 7524798
[TBL] [Abstract][Full Text] [Related]
34. [Results of a multicentric clinical study of mezlocillin in Japan (author's transl)].
Fujii R
Arzneimittelforschung; 1979; 29(12a):2005-8. PubMed ID: 396930
[TBL] [Abstract][Full Text] [Related]
35. Doripenem monohydrate, a broad-spectrum carbapenem antibiotic.
Matthews SJ; Lancaster JW
Clin Ther; 2009 Jan; 31(1):42-63. PubMed ID: 19243706
[TBL] [Abstract][Full Text] [Related]
36. [Clinical experience of mezlocillin in France (author's transl)].
Konopka CA; Perin G
Nouv Presse Med; 1982 Feb; 11(5 Pt 2):378-82. PubMed ID: 6460980
[TBL] [Abstract][Full Text] [Related]
37. [Current antibiotics series I: Piperacillin].
Ueda Y; Matsumoto F
Jpn J Antibiot; 1983 Apr; 36(4):653-77. PubMed ID: 6224033
[No Abstract] [Full Text] [Related]
38. Antibiotic use in neonatal sepsis.
Yurdakök M
Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
[TBL] [Abstract][Full Text] [Related]
39. [Effective treatment of urinary tract infection with carbenicillin].
Yamamoto C; Miyoshi T; Namikawa K; Fukuchi S
Hinyokika Kiyo; 1971 Sep; 17(9):596-600. PubMed ID: 5001081
[No Abstract] [Full Text] [Related]
40. [Therapeutic results obtained with Dicloeta in patients with urinary tract infections].
Lotti T; Muzzonigro G
Minerva Med; 1973 Nov; 64(82):4375-81. PubMed ID: 4128867
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
